Abacavir and Lamivudine
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
NADAC/unit
$1.2621
No Shortage
Tier 1: 19.8%
5 Manufacturers
5 ANDAs
Abacavir and Lamivudine suppresses hepatitis B virus replication.
Generic Manufacturers
AUROBINDO PHARMA LTDCHARTWELL RX SCIENCES LLCCIPLA LTDHETERO LABS LTD UNIT VLAURUS LABS LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
